Quest PharmaTech (TSXV:QPT) FCF Margin % : 0.00% (As of Oct. 2023)

View and export this data going back to 1999. Start your Free Trial

What is Quest PharmaTech FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Quest PharmaTech's Free Cash Flow for the three months ended in Oct. 2023 was C$-0.01 Mil. Quest PharmaTech's Revenue for the three months ended in Oct. 2023 was C$0.00 Mil. Therefore, Quest PharmaTech's FCF Margin % for the quarter that ended in Oct. 2023 was 0.00%.

As of today, Quest PharmaTech's current FCF Yield % is -14.10%.

The historical rank and industry rank for Quest PharmaTech's FCF Margin % or its related term are showing as below:

During the past 13 years, the highest FCF Margin % of Quest PharmaTech was -101.81%. The lowest was -153933.33%. And the median was -77017.57%.

TSXV:QPT's FCF Margin % is not ranked ^*
in the Biotechnology industry.
Industry Median: -141.025
* Ranked among companies with meaningful FCF Margin % only.

Quest PharmaTech FCF Margin % Historical Data

The historical data trend for Quest PharmaTech's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Quest PharmaTech FCF Margin % Chart

Quest PharmaTech Annual Data

Trend

Jan14

Jan15

Jan16

Jan17

Jan18

Jan19

Jan20

Jan21

Jan22

Jan23

FCF Margin %

Get a 7-Day Free Trial

Quest PharmaTech Quarterly Data
	Jan19	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23
FCF Margin %	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Quest PharmaTech's FCF Margin %

For the Biotechnology subindustry, Quest PharmaTech's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Quest PharmaTech's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Quest PharmaTech's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Quest PharmaTech's FCF Margin % falls into.

Quest PharmaTech FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Quest PharmaTech's FCF Margin for the fiscal year that ended in Jan. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Jan. 2023 )	/	Revenue (A: Jan. 2023 )
	=	-0.555	/	0
	=	%

Quest PharmaTech's FCF Margin for the quarter that ended in Oct. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Oct. 2023 )	/	Revenue (Q: Oct. 2023 )
	=	-0.007	/	0
	=	%

Quest PharmaTech FCF Margin % Related Terms

Thank you for viewing the detailed overview of Quest PharmaTech's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Quest PharmaTech (TSXV:QPT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Quest PharmaTech Inc (TSXV:QPT) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

8123 Roper Road NW, Edmonton, AB, CAN, T6E 6S4

Website

http://www.questpharmatech.com

Quest PharmaTech Inc is a Canadian-based pharmaceutical company developing targeted cancer therapy with its lead product MAb AR9.6, under development for a novel target- truncated O-glycans on MUC16 discovered at the University of Nebraska Medical Center. The company is also developing products utilizing proprietary transdermal delivery technologies with a focus on dermatology and wound healing applications.

Executives

Ragupathy Madiyalakan

Director

Quest PharmaTech (TSXV:QPT) Headlines

No Headlines